Table 1: Participant characteristics.

Participant characteristics
( = number)
MSTa ( = 577)LBCQb ( = 410)Perometry
( = 389)
Complete data for MSTa, LBCQb, and perometry ( = 341)

Age: mean (SDc) 62.21 (10.03) 60.99 (9.97) 60.97 (9.95) 60.49 (9.99)
Months since treatment: median (range)54 (0–360)
( = 575 with data)
50 (0–360)
( = 409 with data)
51 (0–360)
( = 387 with data)
49 (0–360)
( = 341 with data)
Wide local excision: (%d) 412 (72.3% of 570) 292 (72.0% of 406) 269 (69.9% of 385) 238 (70.4% of 338)
Mastectomy: (%d)156 (27.4% of 568) 112 (27.8% of 404)114 (29.8% of 384)100 (29.6% of 337)
Axillary surgerye: (%d) 292 (59.3% of 493) 218 (61.5% of 354) 231 (59.6% of 387)179 (60.4% of 297)
Radiotherapy to the breast: (%d)474 (82.5% of 575) 336 (82.2% of 409) 317 (81.7% of 388)278 (81.8% of 340)
Radiotherapy to the axilla: (%d)139 (24.3% of 574) 102 (25.1% of 408)94 (24.4% of 387) 81 (23.8% of 339)

aMST: Morbidity Screening Tool.
bLBCQ: Lymphedema and Breast Cancer Questionnaire.
cSD: standard deviation.
d% frequency of number of participants with data for participant characteristic.
eAxillary surgery includes lymph node clearance, four-node sampling, and sentinel lymph node biopsy.